[{"address1": "4300 El Camino Real", "address2": "Suite 210", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 351 4495", "website": "https://unicycive.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Shalabh K. Gupta M.D., MPA", "age": 51, "title": "Founder, Chairman, CEO & President", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1100000, "exercisedValue": 0, "unexercisedValue": 141224}, {"maxAge": 1, "name": "Dr. Pramod  Gupta Ph.D.", "age": 64, "title": "Executive Vice President of Pharmaceutical & Business Operations", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 40969}, {"maxAge": 1, "name": "Mr. Douglas  Jermasek M.B.A.", "age": 62, "title": "Executive Vice President of Corporate Strategy", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 412500, "exercisedValue": 0, "unexercisedValue": 42029}, {"maxAge": 1, "name": "Mr. John W. Townsend CPA", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 197864, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.59, "open": 0.58, "dayLow": 0.465, "dayHigh": 0.5828, "regularMarketPreviousClose": 0.59, "regularMarketOpen": 0.58, "regularMarketDayLow": 0.465, "regularMarketDayHigh": 0.5828, "payoutRatio": 0.0, "beta": 2.147, "forwardPE": -2.5795, "volume": 1485088, "regularMarketVolume": 1485088, "averageVolume": 1054093, "averageVolume10days": 1436290, "averageDailyVolume10Day": 1436290, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 61755812, "fiftyTwoWeekLow": 0.202, "fiftyTwoWeekHigh": 1.45, "fiftyDayAverage": 0.58234, "twoHundredDayAverage": 0.522, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 36294824, "profitMargins": 0.0, "floatShares": 63074972, "sharesOutstanding": 119705000, "sharesShort": 1523377, "sharesShortPriorMonth": 795150, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0147, "heldPercentInsiders": 0.05308, "heldPercentInstitutions": 0.52367, "shortRatio": 1.93, "shortPercentOfFloat": 0.015700001, "impliedSharesOutstanding": 119705000, "bookValue": 0.065, "priceToBook": 7.9369235, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -37824000, "trailingEps": -0.56, "forwardEps": -0.2, "enterpriseToEbitda": -1.131, "52WeekChange": -0.6274368, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 0.5159, "targetHighPrice": 9.0, "targetLowPrice": 3.0, "targetMeanPrice": 6.25, "targetMedianPrice": 7.25, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 26142000, "totalCashPerShare": 0.218, "ebitda": -32095000, "totalDebt": 681000, "quickRatio": 1.084, "currentRatio": 1.283, "debtToEquity": 9.164, "returnOnAssets": -0.87543, "returnOnEquity": -20.28106, "freeCashflow": -12170500, "operatingCashflow": -28575000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "UNCY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1743810900, "regularMarketTime": 1743796801, "exchange": "NCM", "messageBoardId": "finmb_605176729", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "longName": "Unicycive Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626096600000, "postMarketChangePercent": -1.12425, "postMarketPrice": 0.5101, "postMarketChange": -0.00580001, "regularMarketChange": -0.07409996, "regularMarketDayRange": "0.465 - 0.5828", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1054093, "fiftyTwoWeekLowChange": 0.3139, "fiftyTwoWeekLowChangePercent": 1.5539603, "fiftyTwoWeekRange": "0.202 - 1.45", "fiftyTwoWeekHighChange": -0.93410003, "fiftyTwoWeekHighChangePercent": -0.6442069, "fiftyTwoWeekChangePercent": -62.743683, "earningsTimestamp": 1743418800, "earningsTimestampStart": 1743418800, "earningsTimestampEnd": 1743418800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.2, "epsCurrentYear": -0.155, "priceEpsCurrentYear": -3.3283873, "fiftyDayAverageChange": -0.066439986, "fiftyDayAverageChangePercent": -0.114091404, "twoHundredDayAverageChange": -0.006099999, "twoHundredDayAverageChangePercent": -0.011685821, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-13", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -12.559316, "regularMarketPrice": 0.5159, "marketState": "CLOSED", "shortName": "Unicycive Therapeutics, Inc.", "market": "us_market", "esgPopulated": false, "displayName": "Unicycive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]